Skip to main content
Ghana Medical Journal logoLink to Ghana Medical Journal
. 2012 Sep;46(3):152–157.

The Role of Plasma Melatonin and Vitamins C and B12 in the Development of Idiopathic Tinnitus in the Elderly

A O Lasisi 1, F A Fehintola 2, T J Lasisi 3
PMCID: PMC3645155  PMID: 23661829

Summary

Background

To determine the correlation between plasma levels of melatonin, vitamin C and vitamin B12 and the presence of tinnitus among elderly subjects with unexplained subjective tinnitus.

Method

Prospective involving apparently healthy elderly with subjective tinnitus and those without. Plasma levels of melatonin, vitamin C and vitamin B12 were determined using high performance liquid chromatography and correlation determined by comparing subjects with and without tinnitus.

Result

There were 139 elderly subjects (78 females and 61males), the mean(SD) range of the age was 66.9years (0.77) 60–98 years. Of these 58.3% had tinnitus. The mean (SD) range of the plasma levels of melatoninn was 11.2 pg/mL(4.2) 5.1 pg/mL – 30.2 pg/mL while that of Vitamin C was 0.7 µmol/L (0.1) 0.3 µmol/L – 1.2 µmol/L, and vitamin B12 was 43.0pmol/L (3.1) 25.4 pmol/L – 71.6pmol/L. Comparing the plasma levels of the markers between elderly with and those without tinnitus, the plasma levels of melatonin (p=0.01) and vitamin B12 (p=0.03) were significantly lower among the elderly with tinnitus compared to those without, while the difference in the plasma level of vitamin C (p=0.6) was not.

Conclusion

Low plasma melatonin and vitamin B12 have significant correlation with the development of subjective idiopathic tinnitus among the elderly. This finding suggests the need for the trial of correction of these markers in the reversal or control of tinnitus.

Keywords: tinnitus, elderly, plasma, melatonin, vitamin B12, vitamin C, correlation

Introduction

Tinnitus affects about 10–33% of the elderly, its diverse etiological factors and negative effects on disability and quality of life of the sufferers has necessitated the need for effective and efficacious treatment.13 Various treatment modalities have been proposed, in spite of these treatment strategies the pharmacological treatment of tinnitus has progressed little in the past decades and evidence of proven efficacious pharmacotherapy is not available.1,4,5 This may be evidence of poor understanding of the pathogenesis of tinnitus and the complex interactions of the aetiological factors resulting in tinnitus.

Animal experiments has demonstrated that tinnitus could be central6, 7 or peripheral due to the effect on the cochlea, a direct effect on outer hair cells and slower effect on inner ear cells and/or cochlear nerve810 With the use of Lidocaine, suppression of tinnitus has been reported in 60–73% of the ears and changes in the magnitude of tone-burst otoacoustic emission reported in 60% of the ears.915 The effectiveness of lidocaine may suggest that other drugs with similar structure and mechanisms of action may prove beneficial in the treatment of tinnitus.15 However, the relative ineffectiveness of other neurotropic drugs have been attributed to the multiplicity of the pathological processes underlying tinnitus, uncertainty regarding the anatomic location of the lesion, and a lack of understanding of the physiological mechanisms giving rise to tinnitus.1,4

This is a report of our pilot work on the role of immunobiologic factors on the development of subjective tinnitus among the elderly. We have chosen melatonin because it is a neurohormone which is centrally produced in the pineal gland and it helps in examining the hypothesis of the central origin of tinnitus; in addition the role of antioxidative scanvenging was assessed by including vitamin C and vitamin B12.

Method

Study Design

This was a prospective study of immunobiology of subjective tinnitus among apparently healthy elderly subjects. Subjective tinnitus was assessed by asking respondents if they had a sensation of noise in the ear without an external source of sound.

The participants were drawn from the community tagged to an out-reach programme organized for the detection and prevention of illnesses among the elderly. Included in the study were all elderly men and women above 60 years of age who had no known medical condition while the exclusion criteria involved those with history of diabetes, stroke, hypertension, ear diseases, exposure to noise and ototoxic drugs such as aminoglycosides antibiotics, diuretics; ear infections, ear trauma or ear surgery.

Participants Recruitment

Recruitment commenced by obtaining informed consent from the subjects. The participants have had the opportunity of repeated physical examinations by physicians in the outreach programme and undergone few routine clinical investigations including blood glucose, and urinalysis. Prior to enrolment, participants were taken through an already prepared questionnaire aimed at eliciting otological and general medical conditions. Participants were also asked about history suggestive of allergy and use of some notable medications such as: aminoglycosides, diuretics and 4-amino-quinolines antimalarial drugs.

History of exposure to excessive noise such as working (as)/living near (to) blacksmith shop, radio room/disco room, welding shop etc for at least 2 hours per day for at least 5 days a week was also obtained. General and otorhinolaryngological examination was thereafter carried out and 20 millilitres of whole blood was taken from the antecubital vein, immediately spun and separated for estimation of vitamin B12, vitamin C and melatonin.

The diagnosis of the medical condition were based on simple definitions.16, 17 Diabetes was taken as elevated blood glucose with presence of either of polyuria, polydipsia, polyphagia or complications or those on treatment already by physicians, hypertension defined as elevated blood pressure beyond 140/90mmHg or those already on treatment by physician and stroke referred to as weakness of the limb(s) or slurred speech in a patients with hypertension.

In this study exposure to noise referred to close contact with loud noise such as grinding machine, megaphone speaker, blacksmith workshop etc for not less than 2hours daily either at work or home; history of ototoxic medications referred to consumption of a drug in normal or high doses for at least one week particularly known ototoxic drugs whether prescribed by physicians or quack and ear surgery was taken as any operative intervention of the ear.

We based Meniere disease on a history of vertigo, hearing loss, tinnitus with nausea and/or vomiting; otosclerosis on history of hearing loss confirmed to be conductive with an intact tympanic membrane and arteriosclerosis was defined by the presence of thickened arteries confirmed by feeling the walls of the radial artery or locomotor brachialis - observing the pulsation of the brachial artery at the elbow. The Oyo State Research Ethical Review Committee approved the study.

Quantitative Assay of Melatonin

Sample was prepared by pipetting 10.5ml of the plasma sample to a set of vials, this was diluted with 10.0ml of ultrapure water and 2.0ml of 0.1% of benzene acetic acid was added and swirled. To this was added 5.0ml of a mixture of methanol and Sulphuric acid and then shaken for 5.0 minutes. Sodium sulphate solution was added and finally shaken for 10.0minutes. The mixture was then transferred to a set of centrifuge tubes and samples were centrifuged for 15.0 minutes at the speed of 5000 revolutions per minute (rpm). The sample solution was transferred to another set of sterile vials and analyzed on the High Performance Liquid Chromatography.18

Quantitative Assay of Vitamin B 12

Into a clean beaker, 1.0ml of the sample and 25ml of 0.2 N HCL was added and warmed on a water bath for 30 minutes, then cooled and adjusted the pH to 6.0 using NaOH. This was followed by adding 1N HCL to lower the pH to 4.5, then transfered into a set of 50.0ml centrifuge tubes, shaken for 30minutes and centrifuged for the period of 20.0 minutes at 2000rpm. The supernatant was collected and vitamin B12 determined by High Performance Liquid Chromatography.18

Quantitative Assay of Ascorbic acid

Sample was prepared by pipetting 1.5ml of the plasma into a centrifuge tubes and to this was added 10.0.ml of freshly prepared 0.5% oxalic acid and 10.0ml of a mixture of ultrapure water, acetone and dichloro-phenolmidophenol solution. The mixture was shaken on a mechanical shaker for 30minutes and then centrifuge at 1500rpm for 20minutes. The supernatant was separated into a set of vials and the determination of the vitamin C was done with High Performance Liquid Chromatography.18

As quality control measure, control and standard sera were included in the analysis at every sera assay to ensure reliability and quality of the procedure. An initial pilot study was conducted to test all instruments and this was followed by a preliminary statistical analysis to detect outliers and correct factors.

Data analysis

The main outcome variables were the serum levels of melatonin, vitamin B12 and vitamin C in elderly subjects with report of subjective tinnitus and the control subjects were selected among the elderly without tinnitus.

Economic status was assessed by taking an inventory of household and personal items including chairs, clock, bucket, radio, television set, fans, stove or cooker, car and telephone. The list was composed of 21 such items.

Respondents' economic status was categorized by relating each respondent's total possessions to the median number of possessions of the entire sample. Thus, economic status was rated low if its ratio to the median was 0.5 or less, low-average if the ratio is 0.5 – 1.0, high-average if it was 1.0 – 2.0, and high if it was over 2.0. Residence was classified as rural (less than 12,000 households), semi-urban (12,000 – 20,000 households) and urban (greater than 20,000 households). The data were initially explored using the Stata software; variables were analyzed by unpaired t test both for equal and unequal variance using the variance ratio function of the Stata software to determine the appropriate use of the Satterthwaite's correction for the degrees of freedom. Level of statistical significance was at P < 0.05 for all the analyses.

Result

The subjects included 139 elderly subjects (78 females and 61males), the mean(SD) range of the age was 66.9years (0.77) 60–98years. Of these 81(58.3%) had tinnitus. Tables 1 shows the sociodemographic and lifestyle factors among the subjects, it reveals that there was no significant difference between elderly persons with tinnitus and those without tinnitus in the gender, economic status, educational level, residence and history of lifetime alcohol or tobacco use.

Table 1.

Univariate analysis of the sociodemographic and life-style correlates between the subjects with and without tinnitus

Characteristics Elderly subjects with
Tinnitus (n=81)
Elderly subjects without
Tinnitus (n=58)
p-value
Sociodemographic
Age (years)
60–64
65–69
70–74
75–79
≤80
24(29.6%)
20(24.7%)
17(21.0%)
12(14.8%)
8(9.9%)
19(32.8%)
15(25.9%)
11(19.0%)
7(12.1%)
6(10.3%)
0.3
Gender
Female
Male
45(52.4%)
36(39.4%)
33(59.8%)
25(40.2%)
0.4
Western Education
Tertiary
Secondary
Primary
None
8(4.9%)
12(9.2%)
24(17.5%)
37 (37.5%)
7(7.6%)
11(10.9%)
16(20.1%)
24(42.4%)
0.2
Economic Status
High
High-average
Low-average
Low
9(8.2%)
13(27.7%)
26(34.8%)
33(21.2%)
6 (5.4%)
12 (32.6%)
18(34.8%)
22 (27.2%)
0.2
Residence
Urban
Semi-urban
Rural
21(22.1%)
23(39.0%)
37 (30.7%)
14(15.8%)
17(47.8%)
27 (36.4%)
0.4
Lifestyle correlate
Alcohol drinking, ever
No
Yes
47(49.7%)
34(41.1%)
31(52.7%)
27(45.1%)
0.8
Cigarette smoking, ever
No
Yes
44(52.9%)
37(38.9%)
33(50.5%)
25(48.4%)
0.7

Among the subjects, the mean (SD) range of the plasma levels of melatoninn was 11.2 pg/mL(4.2) 5.1 pg/mL – 30.2 pg/mL while that of Vitamin C was 0.7 µmol/L (0.1) 0.3 µmol/L – 1.2 µmol/L, and vitamin B12 was 43.0pmol/L (3.1) 25.4 pmol/L – 71.6pmol/L. Table 2 compares the plasma levels of melatonin, Vitamin C and vitamin B12 between elderly with and those without tinnitus. It shows that the plasma levels of melatonin (p=0.01) and vitamin B12 (p=0.03) were significantly lower among the elderly with tinnitus compared to those without, while the difference in the plasma level of vitamin C was not.

Table 2.

Analysis of the plasma levels of Melatonin, Vitamin C and vitamin B12 between elderly with and those without tinnitus

Characteristics Elderly subjects with Tinnitus
(Mean ± SD)
Melatonin 11.1 pg/mL ±3.4
Vitamin B12 41.3 pmol/L ± 5.3
Vitamin C 0.7 µmol/L ± 0.03

Discussion

The generation of tinnitus have been linked to damage to the central and peripheral auditory systems, even in cases where an impairment could not be detected by audiometry.1922 Impairment of the auditory system cannot be detected by audiometry if it only causes tinnitus without an accompanying hearing loss. In this study, the main finding is that low plasma melatonin and vitamin B12 have significant correlation with the development of tinnitus among the elderly. Melatonin is a neurohormone produced centrally by the pineal gland; it regulates the sleep-wake cycle by inducing sleepiness and reducing body temperature through its effects on the circadian clock. 23, 24 Several workers have reported that melatonin is useful in the treatment of tinnitus, even in cases associated with sleep disturbance.2428

Concerning vitamin B12, our finding is supported by the report of Shemesh et al.29 They reported that the incidence of vitamin B12 deficiency is significantly higher among patients with tinnitus and noise-induced hearing loss (47%) compared with those with noise induced hearing loss alone and normal subjects who exhibited vitamin B12 deficiency in 27% and 19%, respectively. In addition they reported some improvement in tinnitus and associated complaints in 12 patients following vitamin B12 replacement therapy. These suggest a relationship between vitamin B12 deficiency and dysfunction of the auditory pathway; hence they recommended that routine vitamin B12 serum levels be determined when evaluating patients for chronic tinnitus.

The presence of tinnitus as the only features in these subjects with low plasma vitamin B12 suggest that perhaps tinnitus may be one of the early features of the various neurological abnormalities associated with B12 deficiencies. In this case, the tinnitus is thought to be due to auditory nerve malfunction. Our impression is that correction of the plasma levels of these markers may lead to reversal of tinnitus, however, this needs to be studied in the future. Among other studies of the role of biochemical markers in tinnitus, Baguley 30 identified endogenous dynorphins to be responsible for the excitatory function of glutamate within the cochlea, thus, mimicking the action of sodium salicylate in increasing spontaneous neural activity. Similarly, Simpson and Davies9 postulated that persistent tinnitus was due to role of serotonin and they suggested that disrupted or modified 5 - Hydroxy Triptamine (5HT) function might cause a reduction in auditory filtering abilities and in tinnitus habituation.

Other workers3135 have also found that Zinc influences the biophysiological function of neural membranes and transmission such that in the cochlea, levels of zinc are higher than any other organs of the body and the patients showed a significant decrement in their tinnitus after taking zinc. All these reports might be evidence that research into the biology of tinnitus is still evolving and so the application of the findings in the treatment of this condition.

Notably, the values for the serum levels of these biomarkers from this study are low compared with previously published figures. The mean serum levels of vitamin B12 of 151.0–300.0 pmol/L36, serum vitamin C value greater than 28µmol/L37 and melatonin peak value of 70.6+/−14 pg/mL38 were reported as normal. In our study Melatonin ranged between 5.1 pg/mL and 30.2pg/mL while serum Vitamin C level was between 0.3 µmol/mL and 1.2 µmol/mL and vitamin B12 ranged between 25.4 pmol/L and 71.6 pmol/L.

The low figures in this study may be further evidence of the prevalent low level of nutritional health in our population compared to others. However, the method of storage and assay may also account for the difference in the values reported. However, we conclude from this study that low plasma melatonin and vitamin B12 have significant correlation with the development of subjective idiopathic tinnitus among the elderly.

This finding suggests the need to study the role of correction of these markers in the reversal or control of tinnitus.

Acknowledgement

I thank Prof. BL Salako of the Ibadan-Loyola University Genetics of Hypertension project and Prof Oye Gureje of the Ibadan Study of Ageing project for their generosity and support.

References

  • 1.Dobie RA. A review of randomized clinical trials in tinnitus. Laryngoscope. 1999;109:1202–1211. doi: 10.1097/00005537-199908000-00004. [DOI] [PubMed] [Google Scholar]
  • 2.Lasisi OA, Abiona T, Gureje O. Tinnitus in the elderly: Profile, correlates, and impact in the Nigerian Study of Ageing. Otolaryngol Head Neck Surg. 2010;143(4):510–515. doi: 10.1016/j.otohns.2010.06.817. [DOI] [PubMed] [Google Scholar]
  • 3.Lasisi OA, Gureje O. Prevalence of insomnia and impact on quality of life among community elderly with tinnitus. Ann Otol Rhinol Laryngol. 2011;120(4):226–230. doi: 10.1177/000348941112000402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lockwood AH, Salvi RJ, Burkard RF. Tinnitus. N Engl J Med. 2002;347:904–910. doi: 10.1056/NEJMra013395. [DOI] [PubMed] [Google Scholar]
  • 5.Laurikainen EA, Johansson RK, Kileny PR. Effects of intratympanically delivered lidocaine on the auditory system in humans. Ear Hear. 1996;17:49–54. doi: 10.1097/00003446-199602000-00006. [DOI] [PubMed] [Google Scholar]
  • 6.Anderson G, Lyttkens L, Hirvela C, Furmark T, Tillfors M, Fredrikson M. Regional cerebral blood flow during tinnitus: a PET case study with lidocaine and auditory stimulation. Acta Otolaryngol. 2000;120:967–972. doi: 10.1080/00016480050218717. [DOI] [PubMed] [Google Scholar]
  • 7.Lyttkens L, Larsson B, Wasterstrom SA. Local anaesthetics and tinnitus. Proposed peripheral mechanism of action of lidocaine. ORL J Otorhinolaryngol Relat Spec. 1984;46:17–23. doi: 10.1159/000275679. [DOI] [PubMed] [Google Scholar]
  • 8.Larsson B, Lyttkens L, Wasterstrom SA. Tocainide and tinnitus. Clinical effect and site of action. ORL J Otorhinolaryngol Relat Spec. 1984;46:24–33. doi: 10.1159/000275680. [DOI] [PubMed] [Google Scholar]
  • 9.Simpson JJ, Davies WE. Recent advances in the pharmacological treatment of tinnitus. Trends Pharmacol Sci. 1999;20:12–18. doi: 10.1016/s0165-6147(98)01281-4. [DOI] [PubMed] [Google Scholar]
  • 10.Haginomori S, Makimoto K, Araki M, Kawakami M, Takahashi H. Effect of lidocaine injection of EOAE in patients with tinnitus. Acta Otolaryngol. 1995;115:488–492. doi: 10.3109/00016489509139353. [DOI] [PubMed] [Google Scholar]
  • 11.Duckert LG, Rees TS. Treatment of tinnitus with intravenous lidocaine: a double-blind randomized trial. Otolaryngol Head Neck Surg. 1983;91:550–555. doi: 10.1177/019459988309100514. [DOI] [PubMed] [Google Scholar]
  • 12.Lenarz T. Treatment of tinnitus with lidocaine and tocainide. Scand Audiol Suppl. 1986;26:49–51. [PubMed] [Google Scholar]
  • 13.Lockwood AH, Wack DS, Burkard RS, et al. The functional anatomy of gaze-evoked tinnitus and sustained lateral gaze. Neurology. 2001;56:472–480. doi: 10.1212/wnl.56.4.472. [DOI] [PubMed] [Google Scholar]
  • 14.Ueda S, Aso S, Watanabe Y, Mizukoshi K. Changes in auditory evoked responses during intravenous lidocaine. Acta Otolaryngol Suppl. 1993;504:89–93. doi: 10.3109/00016489309128129. [DOI] [PubMed] [Google Scholar]
  • 15.Berninger E, Nordmark J, Alván G, Karlsson K K, Idrizbegovic E, Meurling L, Alshurbaji A. The effect of intravenously administered mexiletine on tinnitus - a pilot study. Int J Audiol. 2006;45:689–696. doi: 10.1080/14992020600765209. [DOI] [PubMed] [Google Scholar]
  • 16.Lasisi OA, Ayodele JK, Ijaduola GTA. Challenges in the management of childhood sensorineural hearing loss in Subsaharan Africa, Nigeria. Int J Paed Otorhinolaryngol. 2005;70:625–629. doi: 10.1016/j.ijporl.2005.08.009. [DOI] [PubMed] [Google Scholar]
  • 17.Lasisi OA, Sulaiman OA, Afolabi OA. Socio-economic status and hearing loss in chronic suppurative otitis media in Nigeria. Ann Trop Paed. 2007;27:291–296. doi: 10.1179/146532807X245689. [DOI] [PubMed] [Google Scholar]
  • 18.Lasisi OA. The role of retinol in the aetiology and outcome of suppurative otitis media. Eur Arch Oto-Rhino-Laryngol. 2009;266:647–652. doi: 10.1007/s00405-008-0794-6. [DOI] [PubMed] [Google Scholar]
  • 19.Knipper M, Zimmermann U, Müller M. Molecular aspects of tinnitus. Hear Res. 2010;266:60–69. doi: 10.1016/j.heares.2009.07.013. [DOI] [PubMed] [Google Scholar]
  • 20.Shiomi Y, Tsuji J, Naito Y, Fujiki N, Yamamoto N. Characteristics of DPOAE audiogram in tinnitus patients. Hear Res. 1997;108:83–88. doi: 10.1016/s0378-5955(97)00043-9. [DOI] [PubMed] [Google Scholar]
  • 21.Ergemmont JJ. Central tinnitus. Auris Nasus Larynx. 2003;30:S7–S12. doi: 10.1016/s0385-8146(02)00122-0. [DOI] [PubMed] [Google Scholar]
  • 22.Moller AR. Pathophysiology of tinnitus. Otolaryngol Clin North Am. 2003;36:249–266. doi: 10.1016/s0030-6665(02)00170-6. [DOI] [PubMed] [Google Scholar]
  • 23.Saunders JC. The role of central nervous system plasticity in tinnitus. J Commun Disord. 2007;40:313–334. doi: 10.1016/j.jcomdis.2007.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Megwalu UC, Finnel JE, Piccirillo JF. The effects of Melatonin on tinnitus and sleep. Otolaryngol Head Neck Surg. 2006;34:210–213. doi: 10.1016/j.otohns.2005.10.007. [DOI] [PubMed] [Google Scholar]
  • 25.Rudin DO. Glaucoma, “auditory glaucoma”, “articular glaucoma” and the third eye. Med Hypotheses. 1980;6:427–435. doi: 10.1016/0306-9877(80)90056-0. [DOI] [PubMed] [Google Scholar]
  • 26.Simko F, Paulis L. Melatonin as a potential anti-hypertensive treatment. J Pineal Res. 2007;42:319–322. doi: 10.1111/j.1600-079X.2007.00436.x. [DOI] [PubMed] [Google Scholar]
  • 27.Alpini D, Raponi G, Di Berardino F, Cesarani A. Stress reaction tinnitus model: an alarm bell. Argomenti Otorinolaringoiatria Moderna. 2006;11:6–14. [Google Scholar]
  • 28.Rosenberg SI, Silverstein H, Rowan PT, Holds MJ. Effect of Melatonin on tinnitus. Laryngoscope. 1998;108:305–310. doi: 10.1097/00005537-199803000-00001. [DOI] [PubMed] [Google Scholar]
  • 29.Shemesh Z, Attias J, Ornan M, Shapira N, Shahar A. Vitamin B12 deficiency in patients with chronic-tinnitus and noise-induced hearing loss. Am J Otolaryngol. 1993;14:94–99. doi: 10.1016/0196-0709(93)90046-a. [DOI] [PubMed] [Google Scholar]
  • 30.Baguley DM. Mechanisms of tinnitus British Medical Bulletin. 2002;63:195–212. doi: 10.1093/bmb/63.1.195. [DOI] [PubMed] [Google Scholar]
  • 31.Eggermont JJ. On the pathophysiology of tinnitus: a review and a peripheral model. Hear Res. 1990;48:111–1124. doi: 10.1016/0378-5955(90)90202-z. [DOI] [PubMed] [Google Scholar]
  • 32.Zenner HP, Ernst A. Cochlear-motor, transduction and signal-transfer tinnitus: models for three types of cochlear tinnitus. Eur Arch Otorhinolaryngol. 1993;249:447–454. doi: 10.1007/BF00168852. [DOI] [PubMed] [Google Scholar]
  • 33.Muhlnickel W, Helbert T, Taub E, Flor H. Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci USA. 1998;95:10340–10343. doi: 10.1073/pnas.95.17.10340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lockwood AH, Salvi RJ, Coad ML, Towsley ML, Wack DS, Murphy BW. The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Neurology. 1998;50:114–1120. doi: 10.1212/wnl.50.1.114. [DOI] [PubMed] [Google Scholar]
  • 35.Coelho CB, Tyler R, Hansen M. Zinc as a possible treatment for tinnitus. Prog Brain Res. 2007;166:279–285. doi: 10.1016/S0079-6123(07)66026-9. [DOI] [PubMed] [Google Scholar]
  • 36.Woo KS, Kim KE, Park JS, Park JI, Han JY. Relationship between the Levels of Holotranscobalamin and Vitamin B12. Korean J Lab Med. 2010;30(2):185–189. doi: 10.3343/kjlm.2010.30.2.185. [DOI] [PubMed] [Google Scholar]
  • 37.Hampl JS, Taylor CA, Johnston CS. Vitamin C Deficiency and Depletion in the United States: The Third National Health and Nutrition Examination Survey, 1988 to 1994. Am J Public Health. 2004;94(5):870–875. doi: 10.2105/ajph.94.5.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hernández C, Abreu J, Abreu P, Castro A, Jiménez A. Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP. Eur Respir J. 2007;30(3):496–500. doi: 10.1183/09031936.00051906. [DOI] [PubMed] [Google Scholar]

Articles from Ghana Medical Journal are provided here courtesy of Ghana Medical Association

RESOURCES